StevenFrancisPowellMD
Oncology • Sioux Falls, SDHead & Neck Cancer, Hematologic Oncology, Melanoma, Thoracic Cancer
Medical Fellow
Dr. Powell is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1309 W 17th St Ste 101
14-100 Phillips-Wangensteen Building, Mmc 284
Sioux Falls, SD 57104Phone+1 612-626-5031
Education & Training
University of MinnesotaFellowship, Hematology and Medical Oncology, 2010 - 2013- University of MinnesotaResidency, Internal Medicine, 2006 - 2009
University of South Dakota, Sanford School of MedicineClass of 2006
Certifications & Licensure
MN State Medical License 2008 - 2025
SD State Medical License Active through 2025- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Ph1 Administration of VSV-IFNβ-NIS Monotherapy and in Combination With Avelumab in Pts With Refractory Solid Tumors Start of enrollment: 2017 Apr 17
- 9-ING-41 in Patients With Advanced Cancers Start of enrollment: 2019 Jan 04
Roles: Contact
- TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer Start of enrollment: 2016 Mar 14
Roles: Contact, Principal Investigator
- Join now to see all
Publications & Presentations
PubMed
- Palbociclib in Patients With Head and Neck Cancer and Other Tumors WithAlterations: Results From the Targeted Agent and Profiling Utilization Registry Study.Francis P Worden, Evan Pisick, Michael Rothe, Pam K Mangat, Elizabeth Garrett-Mayer
JCO Precision Oncology. 2024-10-01 - Phase I Study of Elraglusib (9-ING-41), a Glycogen Synthase Kinase-3β Inhibitor, as Monotherapy or Combined with Chemotherapy in Patients with Advanced Malignancies.Benedito A Carneiro, Ludimila Cavalcante, Devalingam Mahalingam, Anwaar Saeed, Howard Safran
Clinical Cancer Research. 2024-02-01 - Assessment of Swallowing Function in Patients with Head and Neck Squamous Cell Carcinoma in High vs. Low Dose Cisplatin.Amber Veldman, Annika van Oosbree, Madisyn Braun, Aarabhi Gurumoorthy, William C Spanos
Cancer Investigation. 2023-12-01
Press Mentions
Cancer Patients in Ireland Benefit from Sanford ExpertiseJuly 12th, 2021
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
